“Disulfidptosis-Related Prognostic Model for Breast Cancer: Personalized Guidance for Clinical Management and Immunotherapy Selection”

https://pubmed.ncbi.nlm.nih.gov/38116315

This study constructed a disulfidptosis-related prognostic model for breast cancer, providing personalized guidance for clinical management and immunotherapy selection.